*Helicobacter pylori* is a human pathogen that infects the stomach. More than half of the human population is infected with *H. pylori*, which is major cause of peptic ulcers, gastric cancers and mucosa-associated lymphoid tissue lymphoma. However, the majority of patients infected with *H. pylori* generally remain asymptomatic and never develop significant disease. *H. pylori* has high genetic diversity, and different genotypes of *H. pylori* are involved in different gastroduodenal disorders. The hosts' genetic factors also influence the development of peptic ulcers and gastric cancer, and plenty of evidence has demonstrated that genetics plays a role in susceptibility and contributes to the differences between those who develop *H. pylori* infection, peptic ulcers and gastric cancer.[@b1-gnl-08-575]--[@b3-gnl-08-575]

Numerous single nucleotide polymorphism (SNP) studies have been undertaken to identify candidate genes that most likely play a role in the development of peptic ulcers and gastric cancer.[@b4-gnl-08-575]--[@b8-gnl-08-575] Recently, a genome wide association study (GWAS) and next generation sequencing study identified several genetic loci that confer susceptibility for *H. pylori* infection and gastroduodenal disease.[@b9-gnl-08-575],[@b10-gnl-08-575]

*H. pylori* prevalence is as high as 90% in some countries, but approximately 5% to 10% of a given population is never infected with *H. pylori*, even in the presence of high exposure rates.[@b9-gnl-08-575] A GWAS meta-analysis identified an association between Toll-like receptor 1 (TLR1) and *H. pylori* seroprevalence, suggesting that genetic variations in TLR1 may explain some of the observed variations in individual risk for developing *H. pylori* infection.[@b9-gnl-08-575]

The pathogenesis of different clinical outcomes is multifactorial and includes the virulence of *H. pylori*, environmental factors and host factors. Different types of *H. pylori* virulence factors (CagA, VacA1, babA2, and OipA) result in different prevalence rates of gastroduodenal disease in different geographic areas.

Genetic polymorphisms in the hosts' interleukin (IL)-10, tumor necrosis factor α (TNF-α), IL-IB and IL-1RN genes have served as important candidates.[@b3-gnl-08-575]--[@b8-gnl-08-575] IL-10 is an anti-inflammatory cytokine that downregulates cell-mediated immune responses and cytotoxic inflammatory responses. An IL-10 promoter polymorphism is associated with an increased risk of developing a peptic ulcer and gastric cancer. A hallmark of *H. pylori*-triggered mucosal inflammation is the continuous recruitment of neutrophils and mononuclear cells to the gastric lamina propria.

TNF-α plays a crucial role in the host's immunological defense against *H. pylori* infection. A TNF-α promoter SNP has been shown to be associated with an increased risk for the development of atrophic gastritis, peptic ulcers and gastric cancer. While the TNF-α 1031 and 863 promoter SNPs are significant risk factors for peptic ulcer in combination with *H. pylori* infection in Taiwan,[@b1-gnl-08-575] neither TNF-α 1031 nor 308 TNF-α is a risk factor for peptic ulcer after *H. pylori* infection in the Polish population.[@b10-gnl-08-575] In China, IL-B-511, IL-RN, and TNF-α 308 polymorphisms are not associated with the development of duodenal ulcers.[@b8-gnl-08-575] In Israel, the *H. pylori* iceA1 bacterial strain is associated with duodenal disease in children, and a TNF-α 238 G polymorphism has been found to be a risk factor for the development of peptic ulcers in children infected with *H. pylori*.[@b5-gnl-08-575] In Japan, polymorphisms in interferon-α, rather than IL-1β, are associated with an increased risk of developing gastric ulcers and cancer.[@b4-gnl-08-575] A GWAS that compared samples form duodenal ulcers and healthy controls in Japan identified two susceptible loci at the prostate stem cell antigen gene at the 8q24 and a locus at the ABO blood group gene at 9q34.[@b11-gnl-08-575]

In Korea, several studies have been undertaken to determine the role of polymorphisms in the IL-10 and TNF-α promoter genes in the development of peptic ulcers and gastric cancer. The IL-10-1082/592 and TNF-α 308 genetic polymorphisms were not found to be important risk factors for peptic ulcers and gastric cancer in Korea.[@b6-gnl-08-575] However, genetic polymorphisms in IL-1B and IL-1RN contribute to the development of gastric ulcers and gastric cancer after *H. pylori* infection.[@b7-gnl-08-575] *H. pylori* is a strong risk factor for gastric cancer. However, only a small portion of *H. pylori*-infected subjects eventually develop gastric cancer. Gastric carcinogenesis is affected by several factors, including the strain of *H. pylori*, environmental factors (smoking, high salt intake, and so forth) and host genetics. IL-10 polymorphisms (819C and 592C alleles have complete linkage disequilibrium with 819T) are associated with *H. pylori* infection and smoking, which increase the risk of developing noncardia gastric cancer, especially intestinal type, in Korea.[@b3-gnl-08-575]

In conclusion, host genetic polymorphisms, investigating currently known SNPs, the virulence of *H. pylori* and ethnic and regional differences should be considered when assessing the risk factors for the development of gastric ulcers and cancer.
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